Stock listing
Lang & Schwarz:A40VPX Zero Candida Technologies Inc. Aktie
German listing (Lang & Schwarz) of Zero Candida Technologies Inc. · home listing TSXV:ZCT
Follow Zero Candida Technologies Inc. into a list and get an email when it puts out news.
Home listing price · TSXV:ZCT
$0.105 CAD 0.000 (0.0%)
Close on Nov 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:ZCT
- Day range
- $0.105 – $0.105 CADNov 19, 2026
- Market cap
- $2.05M CADAt the close on Nov 19, 2026 · price × 19.53M shares outstanding
- 52-week range
- $0.105 – $0.280 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $119 CADMedian day 0 shares · 56 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:ZCT · Home | $0.105 CAD | 0.000 (0.0%) | — | $0.105 | $0.105 | $0.105 | $0.105 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:ZCT · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.105 | 0 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.105 | 0 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.105 | 500 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.105 | 0 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.105 | 0 | |
| $0.105 | -0.005 | -4.5% | $0.105 | $0.105 | $0.105 | 30,000 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | -0.030 | -21.4% | $0.120 | $0.120 | $0.110 | 1,000 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | +0.030 | +27.3% | $0.140 | $0.140 | $0.140 | 2,000 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 5,000 | |
| $0.110 | -0.030 | -21.4% | $0.110 | $0.110 | $0.110 | 21,700 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | -0.010 | -6.7% | $0.140 | $0.140 | $0.140 | 500 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 7,000 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 500 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 |
- Ticker
- Lang & Schwarz:A40VPX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news
Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact
Jun 24, 2026
Closed $0.14 (0.0%) on Jun 24, 2026
Zero Candida Announces Corporate Changes
May 25, 2026
Closed $0.19 (0.0%) on May 25, 2026
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Feb 17, 2026
Closed $0.19 (+8.6%) on Feb 17, 2026
Zero Candida Technologies Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 3 in the last 12 months · 12 in all · newest Jun 24, 2026 · oldest 2024
- Decks
- 3 decks · latest July 2025
Where Zero Candida Technologies Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:ZCT · Home listing | TSXV | Canada | CAD |
| LS Exchange:A40VPX | LS Exchange | Germany | EUR |
| Lang & Schwarz:A40VPX · This page | Lang & Schwarz | Germany | EUR |
| Frankfurt:9L2 | Frankfurt | Germany | EUR |
| Cboe Canada:ZCT | Cboe Canada | Canada | CAD |
| OTC:ZCTFF | OTC | United States | USD |
| Stuttgart:9L2 | Stuttgart | Germany | EUR |
Valuation
Price/book 2.2× against a median of 0.3×: 8th lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- −$85,032 CAD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 2.2×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P/TSX Composite
- -0.17
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Zero Candida Technologies Inc. · TSXV:ZCT | US$1.43M | −US$59,297 | n/a | n/a | n/a | 2.2× | n/a | 0.0× | -0.17 |
| Fuse Medical, Inc. · OTC:FZMD | US$2.03M | US$4.31M | 14.8× | 0.5× | 7.8× | 0.3× | 1.5% | 0.4× | 0.54 |
| Nuwellis, Inc. · NASDAQ:NUWE | US$1.84M | −US$6.31M | n/a | −0.7× | n/a | 0.2× | −152.8% | 0.0× | 2.26 |
| Vivos Therapeutics, Inc. · NASDAQ:VVOS | US$1.83M | US$2.11M | n/a | 0.1× | n/a | 0.8× | −107.1% | 0.2× | 1.41 |
| Autonomix Medical, Inc. · NASDAQ:AMIX | US$1.82M | −US$5.87M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.79 |
| Adagio Medical Holdings, Inc · NASDAQ:ADGM | US$1.72M | US$636,010 | 2.1× | n/a | n/a | 0.1× | n/a | 0.1× | 0.69 |
| Escalon Medical Corp. · OTC:ESMC | US$1.71M | −US$1.96M | 0.4× | −0.1× | n/a | 0.3× | 32.8% | 0.0× | -0.06 |
| Therma Bright Inc. · TSXV:THRM | US$1.66M | US$1.64M | n/a | 17.3× | n/a | n/a | n/a | n/a | -0.15 |
| Nexalin Technology, Inc. · NASDAQ:NXL | US$1.45M | US$1.88M | n/a | 6.8× | n/a | 5.5× | n/a | 4.7× | 0.52 |
| Osteopore Ltd. · ASX:OSX | US$1.38M | US$596,356 | n/a | 0.3× | n/a | n/a | −121.8% | n/a | n/a |
| SpectraCure AB · OMXSTO:SPEC | US$980,276 | US$1.11M | n/a | 32.1× | n/a | 0.1× | n/a | 0.1× | n/a |
| Median of the others | US$1.71M | US$870,913 | 2.1× | 0.4× | 7.8× | 0.3× | −107.1% | 0.1× | 0.62 |
Team and board
Officers
| Officer | Role |
|---|---|
| Eli Ben Haroosh | Co-Founder, Director & CEO |
| Irene Zaiton | VP of Operations & Research |
| Tammy Dvir Bar-On | VP Product & Marketing |
| Yosh Dolberg | Senior VP Development & Engineering |
Board
| Director | Role |
|---|---|
| Asher Hozler | Co-Director |
| Dr.Asher Hozler | Co-Director |
| Eli Ben Haroosh | Co-Founder, Director & CEO |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (July 2025) | Investor deck | 10 slides | July 2025 |
| Investor Presentation (July 2025) | Investor deck | 10 slides | July 2025 |
| Investor Presentation (March 2025) | Investor deck | 9 slides | March 2025 |
Financials
Annual, in CAD
Income statement
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Research and development | 381.0K | 1.22M | 1.87M |
| Selling, general and administrative | 911.0K | 1.02M | 649.0K |
| Operating income | -1.29M | -2.24M | -2.52M |
| Interest expense | 0 | 141.0K | 0 |
| Income before tax | -1.03M | -6.28M | -2.51M |
| Net income | -1.03M | -6.28M | -2.51M |
| Earnings per share, basic | -0.05 | -0.32 | -0.13 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | 187.0K | 241.0K | 4.15K |
| Short-term investments | 2.05M | 2.81M | |
| Current assets | 2.40M | 3.19M | 4.15K |
| Total assets | 2.45M | 3.21M | 4.15K |
| Accounts payable | 2.00K | 4.00K | |
| Current liabilities | 1.06M | 853.0K | 25.6K |
| Total liabilities | 1.06M | 872.0K | 25.6K |
| Shareholders' equity | 1.39M | 2.34M | -21.5K |
| Shares outstanding | 19.5M | 19.5M | 19.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash from operations | -740.0K | -940.0K | -669.0K |
| Capital spending | -28.0K | 0 | 0 |
| Free cash flow | -768.0K | -940.0K | -669.0K |
| Cash from financing | 0 | 2.55M | 2.26M |
| Change in cash | -11.0K | 267.0K | 126.0K |
Cap table
Built by 6ix from Zero Candida Technologies Inc.’s releases
- Common shares
- 19,533,037
- Fully diluted
- 19,533,037
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 19,533,037 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 19,533,037 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eli Ben-Haroosh | Co-Founder, Director & CEO · Since at least Nov 25, 2024 |
| John M. Viglotti | SVP Corporate Services · Aug 8, 2025 – Nov 4, 2026 · Past |
Log in to ask 6ix AI your own questions about Zero Candida Technologies Inc.